COMMUNIQUÉS West-GlobeNewswire

GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD)

09/12/2017 - 16:00

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced new results from its ongoing Phase 2a HOPE-KIDS 1 Study of once-daily oral therapy, [...]

Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference

09/12/2017 - 15:30

Subcutaneous (SQ) delivery significantly increases half-life of CB 2679d to 98.7 hours Data supports potential normalization of FIX activity with daily or less-frequent SQ dosing SOUTH SAN FRANCISCO, Calif., Dec. 09, [...]

BeiGene Presents Updated Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) Combined with GAZYVA® (Obinutuzumab) at the 59th American Society of Hematology Annual Meeting

09/12/2017 - 15:00

CAMBRIDGE, Mass. and BEIJING, China, Dec. 09, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Rhizen Pharmaceuticals S.A. receives FDA Fast Track Designation for RP6530 (tenalisib), a highly selective dual PI3K delta/gamma inhibitor for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL)

09/12/2017 - 14:00

La Chaux-de-Fonds, Switzerland, Dec. 09, 2017 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RP6530 (tenalisib), [...]

Myriad Genetics Presents Results From Two Important EndoPredict® Studies at the 2017 San Antonio Breast Cancer Symposium

09/12/2017 - 00:00

SALT LAKE CITY, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict ® are [...]

JDRF welcomes CRA review of diabetes denials

08/12/2017 - 22:46

TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The 300,000+ Canadians and their families living with type 1 diabetes (T1D) across the country welcome today’s announcement that the Government of Canada and the Canada Revenue [...]

Apellis Pharmaceuticals Presents Update on Phase 1b PHAROAH Trial of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) at Annual Scientific Assembly of the International PNH Interest Group (IPIG)

08/12/2017 - 22:34

LOUISVILLE, Ky. and CAMBRIDGE Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ) , a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]

Cytokinetics Announces Presentation of Results From VITALITY-ALS at 28th International Symposium on ALS/MND

08/12/2017 - 22:20

Previously Announced Results from Phase 3 Clinical Trial of Tirasemtiv Shared with ALS Community VITALITY-ALS Did Not Meet Primary or Secondary Endpoints Trial Informs Development of Next Generation Drug Candidate SOUTH [...]

Akari Therapeutics Announces Phase II COBALT trial of Coversin™ in Patients with PNH Met the Primary Endpoint

08/12/2017 - 22:05

Last three patients enrolled into the Phase II COBALT trial on the new dosing regimen (45 mg per Day) saw a more rapid decline in LDH than those in the original dosing regimen. The Day 28 Endpoint was less than or equal [...]

Adamas Announces New Employment Inducement Grant

08/12/2017 - 22:05

EMERYVILLE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted 64 new employees the option [...]

New Sensory Friendly Reading with Dogs Library Event - 12/13/17

08/12/2017 - 22:00

FULLERTON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fullerton Cares Autism Foundation is teaming up with the Fullerton Public Library to provide a sensory friendly reading time where children of all needs can meet, [...]

Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017

08/12/2017 - 20:50

SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination transaction with SELLAS [...]

Burcon Announces Board Change and Confirms No Material Undisclosed Information

08/12/2017 - 18:48

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”), announced that effective today, Mr. Matthew Hall has resigned as [...]

GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT

08/12/2017 - 17:51

GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT Lille (France), Cambridge (Massachusetts, United States), December 8, 2017 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at [...]

GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE

08/12/2017 - 17:51

GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE Lille (France), Cambridge (Massachusetts, Etats-Unis), le 8 décembre 2017 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique engagée dans [...]

Micron Solutions, Inc. Designates Mr. E. P. Marinos as a Director Emeritus and Appoints Mr. Andrei Soran to its Board of Directors

08/12/2017 - 17:33

FITCHBURG, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (“Micron” or the “Company”), announced the retirement of Mr. E. P. (“Lou”) Marinos from the Company’s Board of Directors [...]

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

08/12/2017 - 16:51

OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize [...]

American Health Council Honors Julio C. Soto, MD as “Best in Medicine”

08/12/2017 - 16:46

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The American Health Council honors Julio C. Soto, MD as “Best in Medicine” for his wealth of medical expertise and commitment to increased patient autonomy over their medical [...]

Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line

08/12/2017 - 16:31

THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that its Health and [...]